Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News STEADYMED Ltd STDY

Healthcare Drug Manufacturers - Specialty & Generic
"SteadyMed Ltd is a specialty pharmaceutical company. It has operations in Israel and United States which include research and development, marketing and business development."

Recent & Breaking News (NDAQ:STDY)

SteadyMed to Provide Insights on Recent Corporate Developments and Report Second Quarter 2015 Financial Results

GlobeNewswire August 6, 2015

SteadyMed Completes Program of Human Factors Studies Validating Usability of Trevyent

GlobeNewswire July 7, 2015

SteadyMed and Cardiome Enter Into a License Agreement for the Commercialization Rights to Trevyent(R) Outside the U.S.

GlobeNewswire June 29, 2015

SteadyMed Adds Significant Commercial Expertise to Its Board of Directors With the Appointment of Elizabeth A. Cermak

GlobeNewswire June 18, 2015

SteadyMed to Present at the JMP Securities Life Sciences Conference

GlobeNewswire June 16, 2015

CORRECTING and REPLACING - SteadyMed Reports Recent Developments, Financial Highlights and First Quarter 2015 Financial Results

GlobeNewswire May 14, 2015

SteadyMed Reports Recent Developments, Financial Highlights and First Quarter 2015 Financial Results

GlobeNewswire May 14, 2015

SteadyMed Submits Application for Orphan Drug Designation for Trevyent(R) For Pulmonary Arterial Hypertension

GlobeNewswire May 7, 2015

SteadyMed Granted Additional U.S. Patent With Patent Term Extension

GlobeNewswire April 22, 2015

SteadyMed Appoints David W. Nassif as Its Full Time Executive Vice President and Chief Financial Officer

GlobeNewswire April 8, 2015

SteadyMed Announces Closing of Initial Public Offering

GlobeNewswire March 25, 2015

SteadyMed Announces Pricing of Initial Public Offering

GlobeNewswire March 20, 2015